01—Abstract
Summary
Summary of the 8-K filed January 31, 2024. Cited figures are marked; the original filing is the authoritative source.
Qualcomm (QCOM) reported fiscal Q1 2024 results (quarter ended December 24, 2023) that beat the high end of its guidance range on both revenue and EPS.
GAAP revenue was $9.935 billiona, up 5% year over year, and GAAP diluted EPS was $2.46, up 24%. Non-GAAP revenue was $9.922 billion (+5%) and non-GAAP diluted EPS was $2.75 (+16%). Growth was led by the QCT semiconductor segment, where revenue rose 7% to $8.423 billion and EBT margin expanded to 31% from 28%.
Handsets grew 16% and Automotive grew 31% to a record quarterly level, partly offset by a 32% decline in IoT revenue. QTL licensing revenue fell 4% to $1.460 billionb. Profitability improved meaningfully.
GAAP operating income rose about 19% to $2.928 billionc, and GAAP net income rose 24% to $2.767 billion. The company also benefited from a sharp drop in cash taxes relative to tax expense. Operating cash flow was $2.949 billion, versus $3.095 billion a year earlier, and capital expenditures fell to $214 million.
Shareholder returns totaled $1.7 billiond, including $895 million in dividends ($0.80 per share) and $784 million in buybacks of 6 million shares. Cash and cash equivalents fell to $8.1 billion, while total debt of about $15.5 billion was largely unchanged.
Management's forward-looking guidance, including the Q2 EPS outlook, was included in the press release but is not reproduced in the excerpt provided. Investors should note that the GAAP-to-non-GAAP gap is driven partly by a $147 million tax benefit tied to the capitalization of R&D expenditures, a temporary item.
02—Key points
Key Highlights
- Revenue of $9.935B (GAAP), up 5% YoY, exceeded the high end of guidance; GAAP diluted EPS of $2.46 rose 24% and non-GAAP EPS of $2.75 rose 16%.
- QCT revenue grew 7% to $8.42B with EBT margin expanding to 31% from 28%; Handsets rose 16% and Automotive hit a record, up 31% to $598M.
- IoT revenue fell 32% to $1.14B, a notable drag on QCT growth that investors should monitor.
- QTL licensing revenue declined 4% to $1.46B, though segment EBT margin remained high at 74%.
- Tax expense was low (GAAP effective tax rate of roughly 5%), and a $1.0B gap between tax provision and cash taxes paid supported operating cash flow, which fell to $2.95B from $3.10B.
- Returned $1.7B to shareholders ($895M dividends at $0.80/share and $784M in buybacks), while cash fell to $8.1B and long-term debt rose to $14.6B.
- Non-GAAP results exclude share-based compensation of $602M, acquisition-related items, and the favorable R&D capitalization tax benefit, which diminishes over time.
03—Questions
Frequently Asked Questions
Did Qualcomm beat its guidance for the quarter?
Yes. Management stated that both revenue and EPS exceeded the high end of the company's guidance range for fiscal Q1 2024. The excerpt does not include the specific guidance ranges.
What drove the strong EPS growth?
GAAP diluted EPS rose 24% to $2.46, driven by 19% operating income growth, lower interest expense relative to income, and a low tax expense of $151M. Investment and other income also rose to $212M from $76M. Non-GAAP EPS grew a more modest 16% to $2.75.
Is the IoT weakness a concern?
IoT revenue fell 32% to $1.14B, which is a significant decline within QCT. Growth in Handsets and Automotive more than offset it in this quarter, but sustained IoT weakness could limit diversification away from handsets.
How is Qualcomm returning capital and managing its balance sheet?
The company returned $1.7B in the quarter, including $895M in dividends and $784M in buybacks. Cash and equivalents fell to $8.1B, while long-term debt increased to $14.6B and total liabilities were $29.1B against $23.1B of equity. Investors should weigh the dividend and buyback pace against the lower operating cash flow.
Are the non-GAAP adjustments material to the investment case?
The adjustments are significant. Non-GAAP EPS of $2.75 exceeds GAAP EPS of $2.46 by $0.29, mainly from share-based compensation of $602M and the R&D capitalization tax benefit. Investors should evaluate both GAAP and non-GAAP measures, since share-based compensation is a real recurring expense.
04—Continue